← Back to Search

Comprehensive Discharge Planning for Frail Elderly (HOME Trial)

Q: What is the highest participant count for this clinical experiment?

<p>Affirmative. Clinicaltrials.gov notes that this clinical trial has been actively searching for participants since November 7th 2019, and was last revised on May 19th 2022. The study needs 72 patients from a single medical site to participate in the trials.</p>

Q: Does this medical trial have vacancies for participants?

<p>According to clinicaltrials.gov, this trial is ongoing and actively recruiting. It was launched on November 7th 2019 with the most recent update made on May 19th 2022.</p>

N/A

Recruiting

Led By Véronique Provencher

Research Sponsored by Université de Sherbrooke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

70 years or older

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up in the hospital at baseline (t1); at the patient's home 1 month (t2) and 3 months (t3) after discharge

Awards & highlights

HOME Trial Summary

This trial is testing a new discharge protocol called HOME, to see if it increases the ability of frail older adults to perform activities of daily living and reduces readmission rates.

Who is the study for?

This trial is for frail elderly individuals aged 70 or older who have mild cognitive impairment and are expected to stay in the hospital for at least 5 days. They must be planning to return home after discharge, speak French or English, and have a family member willing to participate.Check my eligibility

What is being tested?

The 'HOME' intervention is being tested, which includes collaborative goal setting with patients and families, pre- and post-discharge home assessments for safety and needs, plus follow-up support calls aimed at improving daily functioning and reducing readmissions.See study design

What are the potential side effects?

Since 'HOME' is a non-medical intervention focusing on discharge planning rather than medication or procedures, it does not have typical side effects. However, participants may experience stress or anxiety during the process.

HOME Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 70 years old or older.

HOME Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ in the hospital at baseline (t1); at the patient's home 1 month (t2) and 3 months (t3) after discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~in the hospital at baseline (t1); at the patient's home 1 month (t2) and 3 months (t3) after discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and in the hospital at baseline (t1); at the patient's home 1 month (t2) and 3 months (t3) after discharge for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline Functional autonomy measure (SMAF) at 1 and 3 months after discharge

Change in Unplanned hospital readmissions at 1 and 3 months after discharge

Secondary outcome measures

Change from baseline Goal attainment scaling (GSA) at 3 months after discharge

HOME Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: ExperimentalExperimental Treatment1 Intervention

HOME will be delivered by a community-based OT, who will be involved in the hospital discharge planning, trained by the PI. The HOME intervention comprises 4 phases: Phase 1 (in hospital): The clinician will focus on building a rapport with the patient and family members. Information will be gathered about the participant's home environment and functional ability. Phase 2 (± 5 days prior to expected discharge): Clinician will conduct a pre-discharge home assessment with patient and family to evaluate the environment, identify potential problems, and suggest appropriate ways to address them. Phase 3 (<1 week after discharge): Post-discharge home assessment will be conducted to provide additional in-home training and follow up on any of the patient's unmet needs. Phase 4 (2-4 weeks post-discharge): Follow-up telephone calls will be made to provide ongoing support to participant and family and encourage self-problem solving and independence.

Group II: Usual careActive Control1 Intervention

Usual care group will receive the customary discharge planning assessment by a different clinician (OT). During this assessment, according to usual care, information regarding the participants' ability to perform activities of daily living and regarding their home environment is gathered and used to plan for discharge. Usual care group will not receive an OT home assessment as this is not part of usual care. If the clinician identifies a potential need for assistive equipment and home modification needs, patients will be referred to community-based homecare services as is the current practice, and a home visit may be performed following discharge, typically after an lengthy wait (weeks, months) for service.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor

292 Previous Clinical Trials

69,369 Total Patients Enrolled

Canadian Institutes of Health Research (CIHR)OTHER_GOV

1,343 Previous Clinical Trials

26,453,021 Total Patients Enrolled

Véronique ProvencherPrincipal InvestigatorUniversité de Sherbrooke

Media Library

HOME Clinical Trial Eligibility Overview. Trial Name: NCT04154917 — N/A

Frail Elderly Research Study Groups: Experimental, Usual care

Frail Elderly Clinical Trial 2023: HOME Highlights & Side Effects. Trial Name: NCT04154917 — N/A

HOME 2023 Treatment Timeline for Medical Study. Trial Name: NCT04154917 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the highest participant count for this clinical experiment?

"Affirmative. Clinicaltrials.gov notes that this clinical trial has been actively searching for participants since November 7th 2019, and was last revised on May 19th 2022. The study needs 72 patients from a single medical site to participate in the trials."

Answered by AI

Does this medical trial have vacancies for participants?

"According to clinicaltrials.gov, this trial is ongoing and actively recruiting. It was launched on November 7th 2019 with the most recent update made on May 19th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Effectiveness of a Comprehensive Patient-centered Hospital Discharge Planning Intervention for Frail Older Adults

Véronique Provencher 2019. "Effectiveness of a Comprehensive Patient-centered Hospital Discharge Planning Intervention for Frail Older Adults". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04154917.